文献速递主动脉疾病

老年复杂腹主动脉瘤手术修复与观察的成本效果分析

Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients.
PubMed 文献 · J Vasc Surg · 2025-10-09

本研究采用概率马尔可夫模型,比较老年复杂腹主动脉瘤患者接受开窗腔内修复(FEVAR)、开放手术修复(OSR)与观察的终身成本和质量调整生命年(QALY)。结果显示,在多数场景下FEVAR和OSR相比观察具有成本效果,但年龄>80至85岁且动脉瘤较小(男性≤7.0 cm、女性≤6.0 cm)时例外。

要点

  • FEVAR在70岁男性和女性中QALY优于OSR,且成本相当。
  • FEVAR vs观察的增量成本效果比分别为男性$27,621/QALY、女性$21,653/QALY。
  • 年龄>80至85岁且动脉瘤较小者,手术修复可能不具成本效果。

核心结论

  • 对于多数患者,包括老年人,FEVAR和OSR相比观察具有成本效果。

研究设计与样本

  • 概率马尔可夫模型,比较FEVAR、OSR与观察的终身成本和生存(QALY)。
  • 队列接受修复者暴露于并发症、再干预或死亡风险,观察者暴露于破裂风险。
  • 基线死亡率根据国家生命表建模,并进行年龄、性别和动脉瘤大小的敏感性分析。

主要发现

  • 70岁男性5.5 cm动脉瘤:FEVAR vs OSR的QALY为6.5 vs 5.7。
  • 70岁女性5.0 cm动脉瘤:FEVAR vs OSR的QALY为8.0 vs 7.2。
  • 上述队列中FEVAR与OSR成本相当,FEVAR更优。
  • FEVAR vs观察的增量成本效果比:男性$27,621/QALY,女性$21,653/QALY。

关键数值与推荐

  • 年龄>80至85岁且动脉瘤较小(男性≤7.0 cm,女性≤6.0 cm)时,手术修复不具成本效果。

临床怎么用

  • 在多数老年复杂腹主动脉瘤患者中,FEVAR或OSR相比观察具有成本效果。
  • 对于年龄>80至85岁且动脉瘤较小的患者,应审慎评估手术修复的成本效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The operative risks and financial costs associated with fenestrated endovascular aneurysm repair (FEVAR) and open surgical repair (OSR) of complex abdominal aortic aneurysms may not be justified in elderly patients because of limited expected survival. We performed a cost-effectiveness analysis to determine whether FEVAR or OSR was preferable to observation in elderly patients with complex abdominal aortic aneurysms. METHODS: We constructed a probabilistic Markov model comparing lifetime costs and survival (in quality-adjusted life years or QALYs) among patients undergoing FEVAR vs OSR vs observation. Cohorts undergoing aneurysm repair were exposed to risk of complications, reintervention, or death, whereas those undergoing observation were exposed to risk of rupture. Baseline mortality was modeled from a national life table. Outcomes were costs in U.S. dollars, QALYs, and incremental cost-effectiveness ratios. Sensitivity analyses were performed for various combinations of age at the time of repair (range: 50-90 years), sex, and aneurysm size (range: 5.5-8.5 cm/5.0-8.5 cm in men/women, respectively). RESULTS: FEVAR tended to have better survival than OSR for 70-year-old men with 5.5-cm aneurysms (6.5 vs 5.7 QALYs, respectively) and 70-year-old women with 5.0-cm aneurysms (8.0 vs 7.2 QALYs, respectively). However, FEVAR and OSR led to comparable costs in these cohorts. As such, FEVAR was preferred over OSR in these cohorts. Incremental cost-effectiveness ratios of FEVAR vs observation were $27,621 and $21,653 per QALY gained in men and women, respectively. Both FEVAR and OSR were cost-effective compared with observation for most scenarios, except for age >80 to 85 years with smaller aneurysms (≤7.0 cm in men and ≤6.0 cm in women). CONCLUSIONS: FEVAR and OSR are cost-effective compared with observation for most patients, even among elderly.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Minami HR, Greenleaf EK, Nejim BJ, et al. Cost-effectiveness analysis of surgical repair versus observation of complex abdominal aortic aneurysms in elderly patients. J Vasc Surg. 2025. PMID: 41067588. doi:10.1016/j.jvs.2025.09.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。